TABLE 2.
Patient | C‐01 | C‐02 | C‐03 | C‐04 | C‐05 | C‐06 | C‐07 | C‐08 | C‐09 |
---|---|---|---|---|---|---|---|---|---|
Chief complaint | DD | Multiple anomaly | Multiple anomaly | DD | DD | DD | DD | DD | DD |
Sex (M:F) | M | F | M | M | F | M | M | M | F |
Maternal preeclampsia | − | − | − | − | − | − | |||
NICU care | + | + | − | + | − | − | |||
Growth profile | |||||||||
Short stature at diagnosis | + | + | + | − | − | + | + | − | |
Microcephaly at diagnosis | + | + | + | + | + | − | + | − | |
Short stature at last follow‐up | + | + | + | + | − | − | |||
Obesity a at last follow‐up | − | + | − | − | + | − | |||
Clinical phenotype | |||||||||
Hypertrichosis | + | + | + | + | + | + | + | + | |
Low ant hairline | + | + | + | + | + | + | + | ||
Arched eyebrows | + | + | + | + | + | + | + | + | |
Long eyelashes | + | + | + | + | + | + | + | ||
Narrow forehead | + | + | + | + | + | + | + | ||
Convex nasal ridge | + | + | + | + | + | + | + | ||
Large nose | + | + | + | + | |||||
Columella below alae nasi | + | + | + | + | + | + | + | + | |
High arched palate | + | + | + | + | + | + | |||
Micrognathia | − | + | + | + | + | + | |||
Low‐set ears | + | + | |||||||
Broad thumbs | + | + | + | + | + | + | + | + | |
Angulated thumbs | + | − | + | − | − | − | |||
Broad halluces | + | + | + | + | + | + | + | + | |
Polydactyly | − | + | − | + | − | − | − | − | + |
Strabismus | +, BIO myectomy | +, BIO myectomy | + | +, BIO myectomy | +, BIO myectomy | − | +, BIO myectomy | − | + |
Other eye problem | − |
+, glaucoma‐like disc |
+, ONLD | − |
+, optic disc coloboma |
− | − | − | − |
Congenital heart defect | − | − | +, ASD | +, PDA | − | − | − | +, PDA | − |
Genitourinary problem | − | − |
+, VUR grade 4, cryptorchidism orchipexy |
+, cryptorchidism orchipexy |
− | +, micropenis |
+, cryptorchidism orchipexy |
− | − |
Gastrointestinal problem | +, GER | +, GER | +, GER | +, GER | − | − | − | − | + |
Scoliosis | − | − | + | − | − | − | − | − | − |
Other bone problem | − | − | − | − | − | − | − | +, funnel chest | − |
Seizure | − | − | − | − | − | − | − | − | + |
CNS abnormality | − | − | +, tethered cord syndrome | − | +, Suspected posterior PVWM volume loss | − | +, Chiari malformation type I | +, delayed myelination | − |
Keloid | − | − | + | − | − | − | − | − | − |
Malignant tumor | +, ALL | − | − | − | − | − | − | − | − |
Intellectual disability, IQ | + | + | + | + | + | +, 40 | +, 47 | + | + |
Age at walk alone (month) | 21 | 27 | 24 | 27 | 32 | 40 | 20 | ||
Autism | − | − | − | − | − | + | − | + | − |
Aggressive behavior | − | − | − | − | − | − | − | − | − |
Genetic background | |||||||||
Causative gene | CREBBP | CREBBP | CREBBP | CREBBP | CREBBP | CREBBP | CREBBP | CREBBP | CREBBP |
Variant type | Frameshift | Frameshift | Frameshift | intragenic large deletion | Frameshift | Frameshift | Frameshift | intragenic large deletion | nonsense |
Exon | exon 13 | exon 3 | exon 8 | exon 25 | exon 31 | exon 30 | exon 16 | ||
Coding sequence c | c.2469_2470del | c.955_961del | c.1712_1716del | c.4189_4192del | c.5948del | c.4944dup | c.3121C>T | ||
Protein‐based sequence d | p.Gln823Hisfs*8 | p.Val319Thrfs*33 | p.Ile571Asnfs*13 | p.Phe1397Leufs*61 | p.Pro1983Glnfs*16 | p.Pro1983Glnfs*16 | p.Gln1041* | ||
Exonic deletion | exon 6–31 del | exon 6–31 del |
C‐10 | C‐11 | C‐12 | C‐13 | C‐14 | C‐15 | C‐16 | E‐01 | E‐02 | E‐03 | E‐04 |
---|---|---|---|---|---|---|---|---|---|---|
DD | DD | DD | Dysmorphic face | DD | Seizure, known CP | Dysmorphic face | DD | Dysmorphic face | DD | DD |
F | M | F | M | M | F | M | F | M | M | M |
− | − | − | − | − | − | − | + | − | ||
− | − | + | + | + | − | + | − | − | ||
+ | − | + | + | + | + | + | + | |||
+ | + | − | + | + | ||||||
+ | + | + | + | + | + | + | ||||
− | − | − | − | − | − | + | ||||
+ | + | + | + | + | + | b | + | + | + | |
+ | + | + | + | + | + | |||||
+ | + | + | + | + | + | + | ||||
+ | + | + | + | + | + | |||||
+ | + | + | + | + | + | |||||
+ | + | + | + | + | + | |||||
+ | + | − | + | + | ||||||
+ | + | + | + | + | − | + | ||||
+ | + | + | ||||||||
+ | + | + | ||||||||
+ | − | |||||||||
+ | + | + | + | + | + | + | + | + | ||
− | − | − | + | − | ||||||
+ | + | + | + | + | + | + | + | |||
− | − | + | − | − | + | − | − | − | ||
− | − | − | − | − | − | − | − | − | − | − |
− | − | − | − | − | − | − | − | +, visual impairment | +, ptosis | |
− | +, ASD | +, ASD | + | − | − | +, PDA | − | − | − | − |
− | +, Orchiopexy | − | + Orchiopexy, micropenis | +, Orchiopexy | − | − | − | − | − | + |
− | + | + | − | − | − | + | + | − | − | |
− | − | − | − | + | − | − | − | + | − | − |
+, Anterior wedging of T11‐12 spine | +, left coronal synostosis | +, dislocation of radial head | − | − | ||||||
− | − | − | − | − | + | − | − | − | − | − |
− | − | − | − | +, arachnoid cyst | +, Chiari I malformation | − | − | +, Tethered cord syndrome | +, Moyamoya disease | +, inferior vermian hypoplasia |
− | − | − | − | − | − | − | − | − | − | − |
− | − | − | − | − | − | − | − | − | − | − |
+, 34 | + | + | + | + | +, 34 | + | + | + | +, 52 | +, 51 |
42 | 24 | 24 | 48 | 26 | 14 | 15 | ||||
− | − | − | − | − | − | − | − | − | − | + |
− | − | − | ‐ | + | − | − | − | − | + | − |
CREBBP | CREBBP | CREBBP | CREBBP | CREBBP | CREBBP | CREBBP | EP300 | EP300 | EP300 | EP300 |
Intragenic large deletion | Nonsense | Intragenic large deletion | Intragenic large deletion | Frameshift | Frameshift | Intragenic large deletion | Splicing variant | Frameshift | Frameshift | Frameshift |
Exon 17 | Exon 27 | Exon 27 | Intron 24 | Exon 27 | Exon 5 | Exon 14 | ||||
c.3307C<T | c.4400_4401del | c.4482dup | c.4173‐2A>G | c.4384C>T | c.1179_1180del | c.2520del | ||||
p.Arg1103* | p.Val1467Aspfs*11 | p.Lys1495Glnfs*24 | Exon 25 skipping | p.Arg1462* | p.Ala394Ilefs*16 | p.Thr841Profs*9 | ||||
Exon 1 del | Exon 6–31 del | Exon 1–3 del | Exon 17–31 del |
U‐01 | U‐02 | U‐03 | U‐04 | U‐05 |
---|---|---|---|---|
Keloid | DD | DD | ||
F | M | F | M | M |
− | − | − | ||
+ | − | − | ||
− | + | |||
+ | + | + | + | |
+ | − | − | ||
− | − | + | − | |
+ | + | |||
+ | ||||
+ | − | |||
+ | ||||
+ | ||||
+ | ||||
+ | ||||
+ | ||||
+ | + | + | ||
+ | ||||
+ | + | |||
− | − | + | ||
− | − | + | ||
+, Congenital glaucoma | +, ONLD | +, Epiblepharon | +, Secondary glaucoma, coloboma, | |
− | + | − | − | + |
− | +, Orchiopexy | − | +, Orchiopexy | +, VUR |
− | − | + | ||
− | − | − | − | |
− | − | − | ||
− | − | − | − | + |
− | − | − | − | |
+ | − | − | − | + |
− | − | − | − | − |
− | + | +, 53 | +, 46 | + |
21 | 23 | |||
− | − | − | ||
− | − | − | − | |
UN | UN | UN | UN | UN |
Abbreviations: ALL, acute lymphoblastic leukemia; ASD, atrial septal defect; BIO myectomy, bilateral inferior oblique myectomy; DD, developmental delay; GER, gastroesophageal reflux; IQ, intelligence quotient; ONLD, obstruction of the nasolacrimal duct; PDA, patent ductus arteriosus; UN, unknown; VUR, vesicourinary reflux.
Body mass index ≥95th percentile for children or ≥25.0 kg/m2 for adults.
Typical face, but no detailed medical records.
References for coding sequences are NM_004380.3 for CREBBP and NM_001429.4 for EP300.
References for protein‐based sequences are NP_004371.2 for CREBBP and NP_001420.2 for EP300.